We are live on ! Find out more
COCH icon

Envoy Medical
COCH

84 hedge funds and large institutions have $319M invested in Envoy Medical in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 13 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 6

5% more funds holding

Funds holding: 80 → 84 (+4)

0% more capital invested

Capital invested by funds: $319M → $319M (+$223K)

0.03% less ownership

Funds ownership: 77.02% → 76.99% (-0.03%)

31% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 13

Holders
84
Holders Change
+4
Holders Change %
+5%
% of All Funds
1.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
9
Reduced
13
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HSBC Holdings
HSBC Holdings
United Kingdom
+$10.2M
2
GCL
Glazer Capital LLC
New York
+$8.08M
3
CF
Cantor Fitzgerald
New York
+$2.85M
4
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
+$973K
5
TCM
Tegean Capital Management
New York
+$681K

Top Sellers

Rank Fund Capital Flow
1
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$9.65M
2
UOC
UBS O'Connor
Illinois
-$4.51M
3
Millennium Management
Millennium Management
New York
-$3.3M
4
MP
Mangrove Partners
Connecticut
-$1.88M
5
Goldman Sachs
Goldman Sachs
New York
-$1.51M
Name Holding Trade Value Shares
Change 		Change in
Stake
GCL
1
Glazer Capital LLC
New York
$32.6M +$8.08M +830,617 +33%
AC
2
Aristeia Capital
Connecticut
$26.1M – – –
Marshall Wace
3
Marshall Wace
United Kingdom
$20.3M – – –
Nomura Holdings
4
Nomura Holdings
Japan
$18.7M – – –
PAMP
5
Polar Asset Management Partners
Ontario, Canada
$14.6M – – –
Millennium Management
6
Millennium Management
New York
$12.3M -$3.3M -339,473 -21%
FTCM
7
Fir Tree Capital Management
New York
$11.8M – – –
DAM
8
DLD Asset Management
New York
$11.4M – – –
Goldman Sachs
9
Goldman Sachs
New York
$11M -$1.51M -155,600 -12%
SCM
10
Saba Capital Management
New York
$10.5M +$188K +19,304 +2%
PC
11
Periscope Capital
Ontario, Canada
$10.5M -$1.46M -150,500 -12%
HSBC Holdings
12
HSBC Holdings
United Kingdom
$10.3M +$10.2M +1,051,000 New
HI
13
HBK Investments
Texas
$7.33M – – –
Hudson Bay Capital Management
14
Hudson Bay Capital Management
Connecticut
$6.84M – – –
SC
15
Sculptor Capital
New York
$5.95M +$539K +55,339 +10%
WA
16
Whitebox Advisors
Minnesota
$5.39M -$420K -43,200 -7%
TCA
17
Taconic Capital Advisors
New York
$5.18M – – –
SCC
18
Spring Creek Capital
Kansas
$4.89M – – –
VI
19
Vestcor Inc
New Brunswick, Canada
$4.89M – – –
Citadel Advisors
20
Citadel Advisors
Florida
$4.89M +$3.88K +399 +0.1%
MCM
21
Moore Capital Management
New York
$4.88M – – –
RCM
22
Radcliffe Capital Management
Pennsylvania
$4.88M – – –
WP
23
Woodline Partners
California
$4.64M – – –
WCMNY
24
Westchester Capital Management (New York)
New York
$4.46M – – –
D.E. Shaw & Co
25
D.E. Shaw & Co
New York
$4.21M -$9.65M -991,816 -70%
1
2 3 4

COCH Hedge Fund Activity: Q1 2022 in Review

84 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical (COCH) for Q1 2022, worth a combined $319M — up 0.07% from $319M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new COCH positions and 6 closed out — a net gain of 4 holders — while 9 added to existing stakes and 13 trimmed.

The largest buyer was HSBC Holdings, opening a new position worth an estimated $10.2M. The largest seller was D.E. Shaw & Co, cutting an estimated $9.65M.

  • 84 institutional investors held Envoy Medical (COCH) as of Q1 2022, up from 80 in Q4 2021.
  • Funds reported $319M of Envoy Medical stock for Q1 2022, up 0.07% quarter-over-quarter.
  • 10 funds opened new Envoy Medical positions in Q1 2022 and 6 closed out, a net change of +4 holders.
  • The largest Envoy Medical buyer in Q1 2022 was HSBC Holdings, an estimated $10.2M added.
  • The largest Envoy Medical seller in Q1 2022 was D.E. Shaw & Co, an estimated $9.65M sold.

Based on aggregated 13F filings for Q1 2022.